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ABSTRACT
The KDM5 family of histone demethylases removes
the H3K4 tri-methylation (H3K4me3) mark frequently
found at promoter regions of actively transcribed
genes and is therefore generally considered to con-
tribute to corepression. In this study, we show that
knockdown (KD) of all expressed members of the
KDM5 family in white and brown preadipocytes leads
to deregulated gene expression and blocks differen-
tiation to mature adipocytes. KDM5 KD leads to a
considerable increase in H3K4me3 at promoter re-
gions; however, these changes in H3K4me3 have
a limited effect on gene expression per se. By
contrast, genome-wide analyses demonstrate that
KDM5A is strongly enriched at KDM5-activated pro-
moters, which generally have high levels of H3K4me3
and are associated with highly expressed genes. We
show that KDM5-activated genes include a large set
of cell cycle regulators and that the KDM5s are nec-
essary for mitotic clonal expansion in 3T3-L1 cells,
indicating that KDM5 KD may interfere with differen-
tiation in part by impairing proliferation. Notably, the
demethylase activity of KDM5A is required for activa-
tion of at least a subset of pro-proliferative cell cycle
genes. In conclusion, the KDM5 family acts as dual
modulators of gene expression in preadipocytes and
is required for early stage differentiation and activa-
tion of pro-proliferative cell cycle genes.
INTRODUCTION
Methylation of histone proteins constitutes important
epigenomicmarks involved in the dynamic regulation of the
genome in response to external cues. Some histone methy-
lation marks are primarily associated with actively tran-
scribed chromatin, whereas other marks are associated with
repressed chromatin (1). These marks may be modulated
as a consequence of transcriptional activity, but they can
also play an active role in modulating transcription. The
formation and removal of these marks at histone residues is
catalyzed by residue-specific histonemethyltransferases and
demethylases, respectively. The biological function of these
has classically been tightly linked to their histonemodifying
catalytic activity; however, recent data indicate that both hi-
stone methyltransferases and demethylases may also modu-
late transcription independently of their histone modifying
activities (2–5).
The histone lysine demethylases 5 (KDM5) are mem-
bers of the family of Jumonji C (JmjC) domain-containing
histone demethylases and specifically removes dimethyl
(me2) and trimethyl (me3) marks from histone 3 lysine 4
(H3K4) (6,7). The KDM5 family is conserved among many
species (8), and in humans and other mammals it comprises
fourKDM5 paralogues, KDM5A,KDM5B,KDM5C, and
KDM5D, which are very similar in structure (Supplemen-
tary Figure S1A). Unlike KDM5A and KDM5B, KDM5C
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and KDM5D are sex-chromosome-specific genes located
on the X and Y chromosome, respectively (9,10). Multiple
studies of KDM5A (11–14) and KDM5B (15–18) have re-
ported an involvement of these in cancer, and some stud-
ies of KDM5C (19,20) and KDM5D (9) indicate that this
could be a common feature of all KDM5 family members.
Genome-wide mapping of binding sites of KDM5A
(21,22), KDM5B (23), and KDM5C (24) have reported
preferential binding to promoter regions, and a study of
KDM5D binding near the Engrailed 2 gene (25) likewise
demonstrated highest occupancy at the promoter region.
More recently, some studies have reported that KDM5 fam-
ily members may also regulate gene transcription from non-
promoter regions, i.e. putative enhancers (24,26–28).
The H3K4me3 mark removed by the KDM5 family
is found primarily at active promoter regions (1,29,30),
whereas the H3K4me2 mark is found at both active pro-
moters (31) and enhancers (1,32). Both marks are consid-
ered activating (1,33), and consequently members of the
KDM5 family have classically been regarded as repressors
of transcription. Thus, a corepressor role through silenc-
ing of gene expression by demethylation of H3K4me3 at
promoters of genes has been described in diverse cellular
processes such as cell cycle progression and cellular senes-
cence (12,13,17,21,22,34), circadian rhythm (3), and mito-
chondrial function (21,35). However, a potential coactivat-
ing function of the KDM5s has also been suggested by
less defined mechanisms such as through the interaction of
KDM5A with pRB (36) or nuclear receptors (37), by the
ability of KDM5B to prevent spreading of H3K4 methyla-
tion into gene bodies (28), and through binding of KDM5C
at enhancer regions where it has been suggested to main-
tain H3K4 mono-methylation levels (38). Furthermore, the
KDM5Drosophila ortholog Lid has also been implicated in
transcriptional activation through a complex where dMyc
masks the demethylase domain (39) through interaction
with and inhibition of the deacetylase Rpd3 (40), or by in-
teracting with the transcription factor FOXO and prevent-
ing its ability to be recruited to promoters (41). In a recent
study of Drosophila knockout (KO) flies, Lid was further-
more found to be required for activation of gene expres-
sion of a set of mitochondrial genes independently of the
demethylase activity but dependent on the PHD domain
that recognizes H3K4me2/3 (4). These reports indicate that
the KDM5s affect transcriptional activity by several differ-
ent mechanisms that may be independent of their demethy-
lase activity.
Histone demethylases have been shown to play an im-
portant role in cellular differentiation (2). One of the most
well studied differentiation processes is adipogenesis, i.e.
the development of fibroblast-like preadipocytes to ma-
ture, lipid-containing adipocytes. Numerous studies over
the past 30 years, in particular studies using themurine 3T3-
L1 preadipocyte cell line, have carefully unraveled major
transcriptional players in adipogenesis (42,43). Stimulation
of adipocyte differentiation with a hormonal cocktail in-
duces a cascade of transcriptional processes that is driven
by at least two waves of transcription factors (TFs), the
first of which includes CCAAT/enhancer-binding protein
 (C/EBP) and the glucocorticoid receptor. These factors
then induce the expression of the second wave of adipogenic
TFs such as C/EBP and peroxisome proliferator-activated
receptor  (PPAR ), which switches on the adipocyte gene
program. A major early event in the differentiation of 3T3-
L1 preadipocytes is mitotic clonal expansion, during which
the cells undergo approximately two rounds of cell divi-
sion. This clonal expansion is driven by C/EBP (44) and
other first wave transcription factors and has been shown
to be required for differentiation (45–47). During 3T3-L1
adipogenesis, histone methylation patterns are dramatically
changed (48–50). Several histonemethyltransferases and hi-
stone demethylases have been reported to play a significant
role in adipocyte differentiation (51,52). However, so far a
role for the KDM5 family in adipocyte differentiation has
not been described.
In the present study, we demonstrate that the KDM5
family is required for activation of pro-proliferative cell cy-
cle genes and differentiation of 3T3-L1 as well as brown
preadipocytes in response to adipogenic inducers. Using
genome-wide approaches, we show that the KDM5s are
required for balancing the levels of the activating mark
H3K4me3 at promoters in 3T3-L1 cells. Interestingly how-
ever, the KDM5s appear to be exerting their main action on
adipogenic gene expression as direct coactivators of a subset
of promoters including promoters driving pro-proliferative
cell cycle genes during adipogenesis.
MATERIALS AND METHODS
Cell culture
3T3-L1 cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% calf serum.
Cells were induced to differentiate two days post confluence
(designated day 0) in DMEM supplemented with 10% fetal
bovine serum (FBS), 1Mdexamethasone (dex), 0.5mM3-
isobutyl-1-methylxanthine (MIX), and 1 g/ml insulin es-
sentially as described previously (53).
Mouse brown preadipocytes immortalized with the SV40
large T antigen were grown in DMEM supplemented with
10% FBS. Cells were induced to differentiate at confluency
(designated day 0) in DMEM supplemented with 10% FBS,
0.5 M dex, 0.5 mM MIX, 20 nM insulin, 1nM T2, and
125 nM indomethacin. From day 2, dex, MIX, and in-
domethacin were omitted from the differentiation medium.
At indicated time points during differentiation a
0.0025mm2-counting chamber was used to count the num-
ber of cells in control and KD samples. Oil red O staining
was performed to evaluate accumulation of lipids in mature
adipocytes. Cells were fixed with 3.7% paraformaldehyde
for 1 hour and stained for 1 hour with filtered Oil red O
solution (0.5 g Oil red O in 100 ml isopropanol) diluted 3:2
in milliQ. Cells were washed in milliQ and microscopy pho-
tographs were taken at 450 nm. Immortalized KDM5A-/-
mouse embryonic fibroblast (MEFs) with re-introduction
of wild-type KDM5A or KDM5A-H483A mutant were
described previously (7).
Bromodeoxyuridine (BrdU) assay
A BrdU assay (Millipore) was used to quantify the amount
of newly synthesized DNA in control and KD cells in ac-
cordance with the manufacturer’s instructions. Briefly, cells
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were seeded in 96-well NUNC plates in five parallel repli-
cates for each condition and 1:500 BrdU reagent was added
to the medium for either 12 h between day 0 and 12 h post-
induction of differentiation or for 24 hours between day 1
and day 2 of the differentiation. Following DNA denatura-
tion, the amount of BrdU incorporation was assessed im-
munochemically as described in the manufacturer’s proto-
col using a spectrophotometer microplate reader at 450 nm.
RNA extraction, cDNA synthesis, and quantitative real-time
PCR
RNA extraction, cDNA synthesis, and quantitative real-
time PCR were performed as previously described (54).
Data were normalized to transcription factor II B (TFIIB)
and a two-tailed Student’s t-test was used to determine sig-
nificance. Sequences of real-time PCR primers can be found
in Supplementary Table S1.
Western blotting and ECL detection
Whole-cell extracts were prepared in SDS-containing buffer
and subjected to western blotting as previously described
(54). The following antibodies were used: anti-PPAR (E-
8; sc-7273, Santa Cruz (SC) Biotechnology), anti-C/EBP
(14AA; sc-150, SC Biotechn.), anti-C/EBP (C-19; sc-
61, SC Biotechn.), anti-KDM5A (ab70892, Abcam), anti-
KDM5B (ab50958, Abcam), anti-KDM5C (A301-034A,
Bethyl lab.), H3K4me2 (9726, Cell Signaling Techn.),
H3K4me3 (8580, Abcam), H3 (2650; Cell Signaling
Techn.), anti-rabbit IgG (P0399, DAKO), and anti-mouse
IgG (P0447, DAKO), anti-TFIIB (sc-225, SC Biotechn.)
was included as a loading control.
Lentiviral production and transduction of 3T3-L1 cells
For KD of KDM5A, -5B, and -5C, shRNA oligos target-
ing one or more of these factors were cloned into pSicoR
PGK puro vectors (Addgene), and lentiviral particles were
produced in human embryonic kidney (HEK) 293T cells
as described in (55). A control vector containing shRNA
targeting luciferase was cloned in parallel. Sequences of
shRNA oligos can be found in Supplementary Table S2.
Pre-confluent 3T3-L1 and BAT-LgT cells were transduced
4 days before induction of differentiation by incubation for
24 h at 37◦C with medium containing lentiviral constructs
and 6 g/ml polybrene (Sigma). After 24 h, the medium
was changed to normal growth medium.
Chromatin immunoprecipitation (ChIP)
ChIP experiments were performed in 3T3-L1 preadipocytes
(day 0), and in 3T3-L1 cells 4 h and 2 days post-induction
of differentiation essentially as previously described (56).
For preparation of material for KDM5A and KDM5C
ChIP-seq, cross-linking of the chromatin was performed
with 2 mM disuccinimidyl glutarate (DSG) (Proteochem)
as described previously (57). Chromatin prepared for
H3K4me3 ChIP-seq was cross-linked in 1% formaldehyde
only. The antibodies usedwere anti-KDM5A (ab70892,Ab-
cam), anti-KDM5C (A301-034A, Bethyl lab.), and anti-
H3K4me3 (8580, Abcam).
RNA-seq preparation and library construction
Total RNA (4 g) obtained from two independent bio-
logical experiments was polyA-selected and subsequently
subjected to fragmentation and cDNA-synthesis using the
TruSeq RNA Sample Prep kit v2 (Illumina). RNA-seq and
ChIP-seq libraries were constructed according to the man-
ufacturer’s instructions (Illumina) as described (58) and se-
quenced on our in-house HiSeq 1500 platform.
Data analysis
Microarray analysis. The microarray data of KDM5A-
/- MEFs stably transduced with either empty vector (EV),
KDM5AWT or KDM5A-H483A mutant (MT) were used
for the analysis. Raw profiling data were normalized with
affy::RMA and further processed using the LimmaR pack-
age (59). A list of differentially expressed genes in cells over-
expressing KDM5A WT compared to control (EV) cells
were called using a FDR <0.1.
RNA-seq data analysis. Sequencing reads were aligned to
the mouse reference genome (version mm9) using Bowtie2
(60). Splice-junction reads were handled by creation of
a pseudo-splice genome, similar to the strategy utilized
in RSEQTools (61) and aligned using Bowtie2 with stan-
dard parameters. Reads were filtered post-alignment for a
MAPQ score greater than or equal to 30. The number of
exon reads for all RefSeq genes was counted using Subread
(62) and differential expression analyses were performed us-
ing DESeq2 (FDR <0.05, paired analysis) (63). Cluster-
ing of RNA-sequencing data was performed using Mfuzz
(64), only including genes with a membership value >0.5
for subsequent analysis. For both microarray and RNA-seq
data, functional enrichment analysis was performed with
HOMER (65) using pathways related to metabolism from
the KEGG database annotation (66,67) and WikiPathways
(68).
ChIP-seq data analysis. ChIP-seq data sets were
mapped to the mm9 genome with STAR (69) set to
not map across splice junctions (–alignIntronMax 1
–outSJfilterIntronMaxVsReadN 0). Tag directories for
each ChIP-seq library were generated using HOMER
(65), where KDM5A and KDM5C ChIP-seq tag counts
were normalized to 10M reads. Since H3K4me3 protein
levels are generally higher in KDM5 KD compared with
control cells, we used a two-stage normalization strategy
to correct for biases in the H3K4me3 libraries and avoid
underestimating the global increase in the H3K4me3
levels in the normalization process. First, genome-scale
normalization on background reads were done by counting
tags in 10 kb windows throughout the genome as described
in (70) and normalized using a relative log expression
(RLE) method normalization (63). Second, the signal
in peaks was normalized for each condition over time,
but not across conditions. This two-stage normalization
scheme assumes that the background is similar for all
conditions (control and KD) and time points and that
the signal for a particular condition is constant for most
sites over time, but can be different between conditions.
Regions enriched for H3K4me3, KDM5A, and KDM5C
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were called in each library with HOMER findPeaks using
the ‘-style histone’ and ‘-F 10’ settings with all other
parameters set at default. For H3K4me3, KDM5A, and
KDM5C peak files, overlapping regions were merged into
one master region file for each factor/mark. Subsequently,
KDM5A and H3K4me3 peaks at each condition were
identified as having 10-fold more average normalized tags
over two replicates relative to the input control. Due to
the lower quality and therefore higher background of the
KDM5C profiles, KDM5C peaks were identified as having
4-fold more normalized tags in both KDM5C replicates
relative to the input control. For analyses of the H3K4me3
libraries, high confidence promoter proximal regions were
identified as being within ±3 kb of transcriptional start site
(TSS) and having more than 50 tags/kb in at least one of
the conditions resulting in a merged region file consisting
of 10,702 H3K4me3 promoter proximal regions. KDM5A
and KDM5C promoter proximal binding sites were de-
fined as being within ±1 kb of TSS and distal binding
sites between 5 and 50 kb away from TSS. Regions with
significantly different levels of H3K4me3 in KD compared
to control at each time point (i.e. day 0, 4 h, day 2) were
identified using DESeq2 (63) with a fold change cut-off at
1.5-fold averaged over the two replicate experiments and a
P-adjusted value <0.05. Clustering of the temporal profile
of H3K4me3 regions during differentiation was performed
withMfuzz, as described above (64). HOMERwas used for
counting tags at identified regions, annotating binding sites
to RefSeq genes, generating average profiles, and count
matrices for heat maps as well as performing motif analyses
in KDM5A promoter binding sites. The University of
California at Santa Cruz (UCSC) Genome Browser (71)
was used for visualization of genome tracks. For analyses of
promoter features, we retrieved 2,742 promoters containing
TATA boxes from the Eukaryotic Promoter Database
(EPDnew) (72). We overlapped these promoter sequences
with the respective gene groups and considered a gene
as having a TATA box in the promoter if it was found
within ±100 bp of the TSS of the RefSeq-annotated gene.
We retrieved the position of 16,026 CpG islands from
the UCSC genome browser (73) and considered a gene
as having a CpG-island promoter when the TSS of the
RefSeq-annotated gene overlapped a UCSC CpG island.
A group of 17,515 RefSeq-annotated promoters were
included as a control.
Statistics. Two-tailed Student’s t-test was used to deter-
mine significance in qPCR analyses. The P-value for the
difference between data in box plots was computed us-
ing Wilcoxon rank sum test. Spearman’s correlation co-
efficient was used to determine the linear correlation be-
tween two data sets. In the cluster analysis, 95% confi-
dence interval around themedians was determined by boot-
strapping and significance was calculated using a non-
parametric Wilcoxon test. The P-value between data con-
taining categorical variables was computed using Pearson’s
Chi-squared test and the two-proportion z-test.
Additional data sets
m5CpG profiles from mature 3T3-L1 adipocytes (day 6
post-induction) (74) was obtained from NCBI Gene Ex-
pression Omnibus (GEO) (accession GSE73434).
Data access
The RNA-seq and ChIP-seq data sets generated in this
study have been submitted to the GEO (http://www.ncbi.
nlm.nih.gov/geo/) under accession number GSE84410. The
raw microarray data is deposited in GEO under accession
number GSE84309.
RESULTS
KD of the KDM5 family inhibits adipogenesis
In order to identify histone demethylases important for
adipocyte differentiation, we constructed a lentiviral short
hairpin RNA (shRNA) library to individually KD a large
number of histone demethylases in 3T3-L1 preadipocytes
(data not shown). Major advantages of the 3T3-L1 model
system are that the cells differentiate in a rather syn-
chronous manner in response to a hormonal cocktail, and
that differentiation does not require addition of PPAR
agonists for differentiation (75). This is important, since
PPAR agonists are very powerful inducers of adipogen-
esis and therefore tend to override modest inhibitors of dif-
ferentiation. Importantly, most of the key adipogenic reg-
ulators identified in this system have proven to hold up in
vivo. The screen identified the KDM5 family among the
top hits required for adipogenesis. Of the KDM5 family
members only KDM5A, -B, and -C are expressed in 3T3-
L1 preadipocytes. These subtypes are expressed at approxi-
mately equal levels and none of the family members display
major regulation at the mRNA level during adipocyte dif-
ferentiation (Supplementary Figure S1B).
To further evaluate the role of the KDM5 family
members in adipocyte differentiation, we knocked down
KDM5A, KDM5B and KDM5C in 3T3-L1 preadipocytes
four days prior to induction of differentiation (Figure 1A
and B). KD of KDM5B alone did not appear to result in
any major effects on the differentiation as indicated by lipid
accumulation (Supplementary Figure S1C and D). How-
ever, the combinedKDofKDM5A andKDM5C, and even
more so KD of all three KDM5s, resulted in a marked in-
hibition of lipid accumulation compared with shLuciferase
control cells (Figure 1C and Supplementary Figure S1C
and D), thereby indicating redundancy between the KDM5
family members. Accordingly, at day 6 of differentiation
the expression levels of adipocyte characteristic genes such
as fatty acid binding protein 4 (Fabp4), perilipin 1 (Plin1),
perilipin 2 (Plin2), and lipoprotein lipase (Lpl) are signifi-
cantly reduced in theKDM5A/B/CKD (KDM5KD) cells,
while genes characteristic of preadipocytes such as delta-
like 1 homolog (Drosophila) (Dlk1) and thrombospondin 1
(Thbs1) are expressed to higher levels compared with con-
trol cells (Figure 1D). Interestingly, KDof theKDM5s does
not seem to influence the initial induction of C/EBP (Fig-
ure 1E and F), which is part of the first wave of transcrip-
tion factors induced during adipogenesis and required for
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Figure 1. KD of KDM5 family members in 3T3-L1 preadipocytes inhibits adipogenesis. Pre-confluent (day -4) cells were transduced with lentivirus ex-
pressing either control luciferase shRNA (control) or shRNA targeting KDM5A, KDM5B, and KDM5C (KD). Cells were induced to differentiate 2 days
post confluency (day 0) using a standard differentiation cocktail. (A) Schematic representation of the experimental setup. (B) mRNA (left) and protein
(right) levels of KDM5A, KDM5B, and KDM5C at day 0 in control cells and KDM5 KD cells. (C) Representatives of phase contrast micrographs from
Oil red O staining performed at day 8 in control and KDM5 KD cells. (D) mRNA levels of adipocyte marker genes (left), and preadipocyte marker genes
(right) at day 6 in control cells and KDM5 KD cells. mRNA (E) and protein (F) levels of the key adipocyte transcription factors C/EBP, PPAR , and
C/EBP during the course of adipocyte differentiation in control and KDM5 KD cells. Error bars represent standard deviation (SD), (n = 3). *P <0.05,
**P <0.01, and ***P <0.005, Student’s two-tailed t-test.
mitotic clonal expansion (75). However, induction of the
key adipogenic second wave factors, PPAR and C/EBP,
around day 2 of differentiation is significantly impaired in
the KD cells (Figure 1E and F). Importantly, around the
same time point at this still early phase in the differentia-
tion process, C/EBP levels decrease in KD compared with
control cells (Figure 1E and F). Collectively, these data indi-
cate that the KDM5 family is required for activation of the
second wave of TFs and for proper progression of 3T3-L1
adipocyte differentiation.
The increase in H3K4me3 promoter levels upon KDM5 KD
has limited impact on gene expression
The KDM5 family of histone demethylases is responsible
for removing the activating histonemarkH3K4me3 primar-
ily located at promoter regions of actively transcribed genes.
We therefore hypothesized that the effect on adipocyte dif-
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ferentiation by the KDM5 KD was the result of increased
levels of H3K4me3 at promoters leading to aberrant activa-
tion of genes. Using western blotting we confirmed that KD
of the KDM5s leads to a global increase in H3K4me3 that
ismaintained throughout adipogenesis, whereas it hasmod-
est effects on H3K4me2 levels (Figure 2A). To be able to
quantify and locate changes in H3K4me3 deposition at the
genome-wide level and correlate this with changes in gene
expression, we performed H3K4me3 ChIP-seq and RNA-
seq in preadipocytes (day 0) and at early time points (4
h and 2 days) during 3T3-L1 differentiation. Importantly,
there is a good concordance between the biological repli-
cates for both H3K4me3 ChIP-seq and RNA-seq data sets
(Supplementary Figure S2). In total, we identify 10,702 pro-
moters with levels of H3K4me3 significantly above back-
ground. In accordance with the total level of H3K4me3 de-
tected by western blot, the average H3K4me3 level at pro-
moters is significantly higher in KDM5KD compared with
control cells (Supplementary Figure S3A). Using a cutoff
of Padj<0.05, >1.5-fold change, we identified 2,145 pro-
moter sites with significantly increased levels of H3K4me3
in KD preadipocytes compared with control cells, whereas
only four promoters have reduced H3K4me3 levels (Figure
2B). Similar patterns are observed at 4 h and day 2 of differ-
entiation (Supplementary Figure S3B). Interestingly, evalu-
ation of the correlation between the increase inH3K4me3 at
promoters in KD relative to control cells and the increase in
gene expression shows that there is only a weak correlation
at all time points (Figure 2C, Supplementary Figure S2C).
Accordingly, for the genes that are associatedwith increased
H3K4me3 signal in the KD cells there is a marginal average
increase in gene expression relative to control cells, which is
a remarkably small effect given the considerable increase in
H3K4me3 levels (Figure 2D).
The majority of promoter sites gaining H3K4me3 sig-
nal upon KDM5 KD are also marked by H3K4me3 in
the control cells (Figure 2E), and we therefore speculated
that the degree to which promoters are already marked
by H3K4me3 could influence the transcriptional impact
of an increase in H3K4me3. To evaluate this possibility,
we grouped the 2145 preadipocyte promoters with gain
in H3K4me3 upon KDM5 KD into quartiles based on
H3K4me3 signal in control cells, with quartile 1 having the
lowest H3K4me3 signal (Figure 2E). The largest fold in-
crease in H3K4me3 in KD compared with control cells is
observed in quartile 1 (Figure 2F), and the average fold
increase in expression of associated genes is also slightly
higher in quartile 1 (Figure 2G). However, genes associ-
ated with quartile 1 promoters are generally expressed at
low levels (Supplementary Figure S3D), and the correlation
between fold increases in H3K4me3 level and fold changes
in gene expression is weak for all of the quartiles (Sup-
plementary Figure S3E). Examples of ChIP-seq profiles of
H3K4me3 promoter sites of the four quartiles as well as the
gene expression of the associated genes are presented in Fig-
ure 2H. These analyses demonstrate a surprising degree of
disconnection between the increased promoter-associated
H3K4me3 signal and induction of transcription by KDM5
KD in 3T3-L1 cells.
KDM5 KD leads to an increase in H3K4me3 at dynamically
regulated promoters
The above analyses investigated the relationship between
the increase in H3K4me3 at promoters and gene expres-
sion in preadipocytes at early time points of the differen-
tiation process. In order to evaluate whether KDM5 KD
disrupts the dynamic changes in the level of H3K4me3 at a
subset of promoters thereby resulting in aberrant gene ex-
pression of these promoters, we performed a temporal pro-
file cluster analysis of the H3K4me3 mark at promoters us-
ing Mfuzz (64). First, we identified all promoter sites that
exhibited differential levels of H3K4me3 in control versus
KD cells at one or more of the analyzed time points (i.e.
day 0, 4 h and/or day 2). Second, we clustered these pro-
moters according to their changes in H3K4me3 levels dur-
ing the early time points of the differentiation (Figure 3A).
In accordance with the global increase in H3K4me3 lev-
els in the KD cells, all identified clusters have significantly
higher levels of H3K4me3 in KD compared with control
cells (Figure 3B). However, as previously observed in the
analysis of all promoters (Figure 2D), the substantial in-
crease in H3K4me3 levels upon KD at these dynamically
regulated promoter regions appears to have very little ef-
fect on the expression of the associated genes (Figure 3C).
Collectively, we find little evidence indicating that the con-
siderable gain in promoter H3K4me3 levels resulting from
KDof the KDM5s is causally related to the changes in gene
expression.
Increased gene expression correlates with increased
H3K4me3 levels
The above analyses indicate that an increase in promoter
proximal H3K4me3 per se is not a strong inducer of gene
expression. We therefore addressed the reverse question, i.e.
whether an increase in transcriptional activity uponKDM5
KD is reflected in an increase in H3K4me3 at the corre-
sponding promoters. To investigate this, we identified a set
of genes that were differentially expressed (Padj <0.05) be-
tween KD and control cells at day 0 (Figure 4A), or at 4 h
and 2 days post-induction of differentiation (Supplemen-
tary Figure S4A). A substantial number of dysregulated
genes are detected at all time points, with the largest number
of dysregulated genes found at day 2 (i.e. 798 regulated genes
at day 0; 825 genes at 4 h; and 1,987 genes at day 2) (Fig-
ure 4A and Supplementary Figure S4A). In line with this,
clustering analyses based on temporal gene expression pat-
tern (day 0 to day 2) in control cells (Supplementary Figure
S4B) reveal that the first wave of gene regulation initiated by
the adipogenic stimuli at day 0 is not greatly affected by the
reduced KDM5 levels, whereas subsequent gene regulation
at day 2 is dysregulated upon KDM5 KD (Supplementary
Figure S4C). Thus, KDM5KD leads to a profound dysreg-
ulation of gene expression at day 2 of adipocyte differenti-
ation.
Notably, a similar number of genes are upregulated and
downregulated in response to KDM5KD at all time points,
supporting the notion that the KDM5s have both activat-
ing and repressive effects on gene expression as reported
in previous studies (28,36–38). For genes activated by the
KDM5 KD, a strong correlation is observed between the
Nucleic Acids Research, 2017, Vol. 45, No. 4 1749
A
0 1
Control
2 4 6 0 1
KD
2 4 6
H3K4me3
H3K4me2
Histone 3
Day
B
2145
4
Control log2(tags/kb)
KD
 lo
g2
(t
ag
s/
kb
)
H3K4me3 promoter signal
G Gene expression
Q1 Q2 Q3 Q4
Lo
g2
(K
D
/c
on
tr
ol
) #
###
###
H3K4me3 signal
1.3 1.1 1.1 1.1
F H3K4me3 signal
Q1 Q2 Q3 Q4
Lo
g2
(K
D
/c
on
tr
ol
)
###
###
###
###
H3K4me3 signal
3.7 2.3 1.8
D
H3K4me3 promoter groups
H3K4me3 promoter sites, day 0
Quartile 1
Quartile 2
Quartile 3
Quartile 4
E
H
3K
4m
e3
 s
ig
na
l
TFIIB
#
2 4 6 8 10
5
6
7
8
9
10
11
C
ρ=0.29
H3K4me3 signal, log2(KD/control)
G
en
e 
ex
pr
es
si
on
lo
g2
(K
D
/c
on
tr
ol
)
H3K4me3 vs. gene expression
−2 0 2 4
−2
−1
0
1
2
#
1.6
H
Ta
gs
/k
b
0 
400 
300 
200 
100 
Mrgprf
Ta
gs
/k
b
Plin3
0 
800 
600 
400 
200 
Ta
gs
/k
b
0 
300 
200 
100 
Hsd3b7
Ta
gs
/k
b
0 
80 
60 
40 
20 
Kcnn4
5kb
150 chr7: 25,155,000 25,160,000
Kcnn4
150
chr7: 134,945,000 134,950,000
Hsd3b7
150
150
chr7:150
150
chr17: 56,430,000 56,435,000
Plin3
150
150
Quartile 1
Quartile 2
Quartile 3
Quartile 4
KD
KD
KD
KD
Control
Control
Control
Control
152,490,000
Mrgprf
152,485,000
ControlInput KD4kb-4kb
Up All
H3K4me3 signal Gene expression
Up All
###
###
1.1 1.02.1 1.4
Lo
g2
(K
D
/c
on
tr
ol
) 2
1
-1
0Lo
g2
(K
D
/c
on
tr
ol
) 2
1
-1
0
140
120
100
80
60
40
20
0
3.0
2.0
1.0
0.5
2.5
1.5
1.0
0.5
0.0
-0.5
1.5
3.5 2.0
Figure 2. H3K4me3 levels are globally increased at promoters upon KDM5 KD. (A). Western blot showing levels of total H3K4me3 and H3K4me2
protein during the course of differentiation in control and KDM5 KD cells with histone H3 and TFIIB included as controls. (B) Scatter plot showing
the normalized log2 H3K4me3 promoter signal (as tags per kb) (i.e. sites located within -3 kb to +3 kb of the transcription start site (TSS)) in control
and KDM5 KD cells at day 0. H3K4me3 sites with significantly higher tag count (Padj<0.05, min 1.5-fold change) in KDM5 KD relative to control
(green) or control relative to KD (red) cells are shown. (C) Scatter plot showing the log2 fold change in H3K4me3 promoter signal related to the log2 fold
change in expression of the nearest genes in KDM5 KD relative to control cells at day 0 at all identified H3K4me3 sites of an expressed gene. H3K4me3
promoter sites with significantly higher tag count (Padj<0.05, min 1.5-fold change) upon KDM5 KD are shown. There are no H3K4me3 promoter sites
with significantly lower tag count in KD relative to control cells of expressed genes. ‘ρ’ indicates Spearman’s correlation coefficient and the black line
shows the linear regression between plotted values (green) of the H3K4me3 sites with significantly higher tag count in KD cells. (D) Box plots showing
log2 fold change in H3K4me3 promoter signal (left) and gene expression (right) in KD relative to control cells at day 0 promoter sites of expressed genes
that significantly gain H3K4me3 signal (green) or at all H3K4me3 promoter sites (gray). (E) H3K4me3 promoter sites were divided into four quartiles
(Q1–Q4) based upon H3K4me3 signal in day 0 control cells with Q1 having the weakest signal. Heat map showing input signal in control cells (left panel)
and H3K4me3 signal in control (middle panel) and KDM5 KD cells (right panel) at day 0 in a ±4-kb window around H3K4me3 promoter sites that
significantly gain H3K4me3 upon KDM5 KD. (F) Box plot showing for day 0 the log2 fold change in H3K4me3 promoter signal in KDM5 KD relative
to control cells in the four quartiles (Q1–Q4) described in E. (G) Box plot showing for day 0 the log2 fold change in gene expression in KDM5 KD relative
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E at the Kcnn4 (Q1),Hsd3b7 (Q2),Mrgprf (Q3), and Plin3 (Q4) loci (left). Gene expression signal (as tags per kb) of the associated genes in control (blue)
and KDM5 KD (red) cells at day 0 (right). D, F and G: P-value: # P < 0.05, ## P <2.2e-8, and ### P <2.2e-16, Wilcoxon rank sum test as indicated or
F) between individual quartiles. Fold change of KD relative to control is included above each box.
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Figure 3. Cluster analysis of temporal H3K4me3 occupancy at promoter sites. (A) All promoter sites with differential levels of H3K4me3 in control relative
to KDM5KD cells at one or more of the analyzed time points were clustered based on the temporal profile of H3K4me3 during the early stage of adipocyte
differentiation (day 0 to 2) in control cells. (B) H3K4me3 promoter signal in the six clusters shown in A in control (blue) and KDM5 KD (red) cells at
day 0. The colored region illustrates the 95% confidence interval around the median (dashed line) as determined by bootstrapping. (C) Expression signal
based on RNA-seq of genes assigned to the promoters from the six different clusters shown in A in control (blue) and KDM5 KD (red) cells at day 0. The
colored region is the 95% confidence interval around the median (dashed line) as determined by bootstrapping. The number of genes in C differs from the
number of promoter sites in A-B due to a subset of the cluster promoter sites being associated with genes not expressed at detectable levels in 3T3-L1 cells,
which were therefore excluded from the analysis. B and C: P-value: # P <0.05, ## P <2.2e-8, and ### P <2.2e-16, control compared with KDM5 KD,
Wilcoxon rank sum test.
increase in gene expression and the increase in H3K4me3 at
the promoter (Figure 4B and Supplementary Figure S4D).
In line with this, the average gain in H3K4me3 at promot-
ers of genes that are upregulated upon KDM5 KD is sig-
nificantly higher than the gain in H3K4me3 at promoters
of downregulated and all analyzed genes (Figure 4C, right).
Notably, genes downregulated upon KDM5 KD do not
lose H3K4me3 signal compared with control cells (Figure
4C, right), consistent with the notion that the H3K4me3
mark is not a main determinant of gene expression. Ex-
amples of ChIP-seq profiles of H3K4me3 promoter sites
and the expression of associated upregulated and downreg-
ulated genes are shown in Figure 4D. Taken together, these
results indicate that rather than promoting gene expression,
theH3K4me3mark is deposited at promoter regionsmainly
as a result of active transcription.
KDM5A binding is strongest near KDM5-activated genes
To explore the mechanisms by which the KDM5s are
involved in gene regulation during the early stages of
3T3-L1 adipogenesis, we performed KDM5A ChIP-seq
in replicates in 3T3-L1 cells at different time points (day
0, 4 h and day 2) of the differentiation. As previously
shown (21,22,76), a large proportion of KDM5A bind-
ing sites (22.0%) are located in the promoter region (TSS
± 1 kb) (Supplementary Figure S5A), and these corre-
late very strongly between replicates (Supplementary Fig-
ure S5B). Furthermore, KDM5A promoter binding sites
display much higher binding intensity than other genomic
regions (Supplementary Figure S5C). A comparable bind-
ing pattern is observed forKDM5C (Supplementary Figure
S5A and S5C), and there is strong correlation between the
binding strength of KDM5A and KDM5C at their target
promoters (Supplementary Figure S5D), thereby indicating
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that these two factors display a similar mode of binding in
3T3-L1 cells.
Interestingly, genes with strong promoter binding of
KDM5A in preadipocytes tend to be induced and gain
H3K4me3 during differentiation (Figure 5A and B, Supple-
mentary Figure S5E), and this gene induction is impaired in
the KDM5 KD cells (Figure 5C). This indicates that high
KDM5A promoter binding at day 0 primes promoters for
activation during early adipogenesis. In contrast, genes with
low KDM5A binding in preadipocytes are predominantly
repressed during differentiation (Figure 5B), and this re-
pression is KDM5-dependent (Figure 5C). Thus, KDM5A
is associated with both induced and repressed promoters
during 3T3-L1 adipogenesis; however, promoters marked
with low KDM5A binding in preadipocytes are generally
repressed in a KDM5-dependent manner during differen-
tiation, whereas promoters with high KDM5A binding are
generally activated in a KDM5-dependent manner during
differentiation.
To further explore the regulatory role of KDM5 in
adipocyte differentiation, we defined a set of KDM5-
activated (i.e. bound by KDM5A and downregulated by
KDM5KD) and KDM5-repressed (i.e. bound by KDM5A
and upregulated by KDM5 KD) genes. KDM5A bind-
ing is significantly stronger at the promoter of these regu-
lated genes compared to regions distal to these genes (Fig-
ure 5D). Furthermore, only minor differences in KDM5A
binding near KDM5-activated and repressed genes are ob-
served at these distal regions, supporting the notion that
KDM5A mainly exerts its effect through the promoter. In
accordance with the analyses above, KDM5A binds signif-
icantly less to promoters of KDM5-repressed genes com-
pared with KDM5-activated promoters and promoters of
all KDM5A target genes (Figure 5D), and these KDM5-
repressed genes are expressed at a lower level and have
lower levels of H3K4me3 at their promoters (Supplemen-
tary Figure S5F andG). These analyses further indicate that
KDM5A functions as a repressor at some promoters, which
are generally low occupancy sites, whereas it acts as an ac-
tivator of a subset of high KDM5A occupancy promot-
ers. Similar promoter-enriched binding toKDM5-activated
genes is observed for KDM5C thereby further supporting a
similar mode of action for KDM5A and KDM5C in 3T3-
L1 cells (Supplementary Figure S5H).
Further characterization of KDM5-activated and
KDM5-repressed promoters at day 2 revealed that KDM5-
activated promoters on average are less associated with a
TATA box and are more associated with CpG islands (Fig-
ure 5E). Furthermore, comparison with DNA methylation
profiles from a previous study (74) showed that KDM5-
activated promoters generally are depleted of m5CpG
signal in 3T3-L1 adipocytes compared to KDM5-repressed
and all target sites (Figure 5F). Interestingly, motif analyses
revealed that the E2F7 motif is specifically enriched at
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Figure 5. KDM5A binds strongly at promoters of KDM5-activated genes. (A) KDM5A promoter sites were divided into four quartiles (Q1-Q4) based on
KDM5A signal in 3T3-L1 preadipocytes with Q1 having the weakest signal. (B) Number of genes that are significantly induced (black) or repressed (gray)
from day 0 to day 2 during differentiation for genes with KDM5A promoter sites in different quartiles (Q1–Q4, defined in A) in control cells. P-value: #
P <0.05, P-value: ## P <2.2e-8 and ### P <2.2e-16. Two proportion z-test between induced and repressed genes in each quartile. (C) Box plot showing
log2 fold change in gene expression signal (as tags per kb) from day 0 to day 2 of differentiation for genes with KDM5A promoter sites in different quartiles
(Q1–Q4) in control (blue) and KDM5 KD (red) cells.D. Box plot showing log2 normalized KDM5A signal (as tags per kb) in promoter sites (±1 kb from
TSS) and distal sites (5–50 kb from TSS) of KDM5-repressed (green), KDM5-activated (red), and all KDM5 target (gray) genes at day 0 (left), 4 h (middle)
and day 2 (right) post induction of 3T3-L1 differentiation. (E) Fraction of promoter sites for each indicated group of KDM5A-associated day 2 promoters
and annotated RefSeq promoters that harbor a CpG island (left) or TATA-box (right). P-value: # P<0.05, ## P<2.2e-8, and ### P<2.2e-16, Pearson’s
Chi-squared test. (F) Aggregate plot showing the average m5CpG signal (as tags per bp per peak) at day 6 post-induction of 3T3-L1 differentiation in
KDM5A day 2 target promoters of KDM5-repressed (green), KDM5-activated (red), and all KDM5 target (gray) genes. (G) The percentage of KDM5A
day 2 promoter sites (orange) or matched genomic background sequences (gray) with the indicated motifs near KDM5-repressed, KDM5-activated, and
all KDM5 target genes. # FDR<0.05 and ### FDR<2.2e-16 between KDM5A promoter groups and background. A, C and D: P-value: # P <0.05,
## P <2.2e-8, and ### P <2.2e-16, Wilcoxon rank sum test, as indicated or A) between individual quartiles and D) between all groups in promoter and
distal regions.
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KDM5-activated promoters at day 2, whereas the ETS
motif is enriched at KDM5-activated promoters and a
control group of all KDM5A-occupied promoters (Figure
5G, Supplementary Table S3), suggesting that members
of the KDM5 family and E2F cooperate in the activation
of these genes. Taken together these results indicate that
the ability of KDM5 to repress or activate promoters may
depend on the promoter context.
The KDM5s are required for activation of cell cycle genes and
proliferation
To characterize the KDM5 target genes that are dysregu-
lated on day 2 in the KDM5 KD cells, we performed func-
tional enrichment analyses using KEGG and WikiPath-
ways on KDM5-activated, -repressed, and unchanged tar-
get genes in day 2KD cells compared with control. Interest-
ingly, among the top five most significantly enriched path-
ways of the KDM5-activated target genes are multiple cell
cycle-related terms in both the KEGG and WikiPathways
analyses (Figure 6A, Supplementary Figure S6A). Genes
in this group include cell cycle genes that are involved in
stimulation of progression through the cell cycle such as
cell division cycle 6 (Cdc6) and Cdc20 (Figure 6B), as well
as genes encoding important cell cycle regulators such as
E2F transcription factor 1 and 2 (E2f1 and E2f2) (Supple-
mentary Figure S6B). These genes display transient expres-
sion profiles that peak around day 2 during differentiation
in control cells (Figure 6B), which is consistent with mitotic
clonal expansion during the early stage of 3T3-L1 differen-
tiation (45–47). Notably, KDM5 KD impairs the induction
of cell cycle genes normally upregulated during early differ-
entiation (Figure 6C, Supplementary Figure S6B), whereas
KDM5 KD does not significantly affect cell cycle genes
that are repressed or unchanged between day 0 and day 2
(Supplementary Figure S6C). Importantly, and in accor-
dance with other KDM5-activated genes in the above anal-
ysis (Figure 5D), the KDM5-activated cell cycle genes also
display enrichment of KDM5A andKDM5C binding (Fig-
ure 6D-E and Supplementary Figure S6D). Upon KDM5
KD, binding of KDM5A as well as KDM5C to the pro-
moters of a subset of pro-proliferative cell cycle genes is sig-
nificantly reduced (Figure 6F), indicating that both KDM5
family members play a direct role in the induction of these
pro-proliferative cell cycle genes. Collectively, these results
show that KDM5KD prevents the full induction of the cell
cycle gene program in response to the adipogenic cocktail
and indicates that KDM5 family members directly coacti-
vate these genes. Consistent with a role of KDM5 in ac-
tivation of cell cycle genes, mitotic clonal expansion be-
tween day 1 and day 3 of differentiation (Figure 7A) as well
as DNA synthesis (Figure 7B) is significantly impaired in
KDM5 KD cells compared with control. Notably, KD of
KDM5 at day 2 of the differentiation, i.e. after activation
of the second wave of major adipogenic transcription fac-
tors and after the post-confluent mitoses, does not interfere
with adipogenesis (Supplementary Figure S6E-H). Collec-
tively, these results shows that KD ofKDM5 interferes with
early stage 3T3-L1 adipogenesis, and indicates that it does
so at least in part by interfering with activation of cell cycle
genes.
To investigate whether KDM5 plays a similar role in
the differentiation of other adipocyte model systems, we
knocked KDM5 down in BAT-LgT cells, which is a brown
preadipocyte cell line immortalized by SV40 large-T anti-
gen (Supplementary Figure S7A). Interestingly and consis-
tent with the results from 3T3-L1 preadipocytes, KDM5
KD in brown preadipocytes also affects the expression of a
subset of cell cycle genes (Supplementary Figure S7B) and
results in impaired proliferation during differentiation (Fig-
ure 7C). Furthermore, KDM5 KD results in reduction in
lipid accumulation (Figure 7D and Supplementary Figure
S7C) as well as expression of adipocyte marker genes and
UCP1 (Figure 7E). Taken together, the KDM5 family is im-
portant for post-confluent proliferation and adipogenesis of
immortalized brown preadipocytes as well as 3T3-L1 white
preadipocytes, suggesting that these are general effects of
KDM5 on ex vivo adipocyte differentiation.
Both gene activation and repression is dependent on KDM5A
enzymatic activity
Our results indicate that the KDM5s primarily promote
adipogenesis by coactivation of specific promoters includ-
ing promoters of cell cycle genes, whereas the general ef-
fect on reducing H3K4me3 at promoters seems to be less
important. To investigate whether the demethylase enzy-
matic activity of the KDM5s is required for the regulation
of cell cycle genes, we used microarray data from KDM5A
KO mouse embryonic fibroblasts (MEFs) stably express-
ing either wild type or an enzymatically inactive mutant of
KDM5A. Similar to the results from differentiating 3T3-
L1 adipocytes, functional enrichment analyses revealed that
gene groups related to the cell cycle and cancer pathways are
significantly enriched among the KDM5A-activated target
genes in KDM5A KO MEFs (Supplementary Figure S8).
The major fraction of these KDM5A-activated cell cycle
genes have previously been reported to be pro-proliferative
and/or have been shown to be overexpressed in various can-
cer forms (77–87). Interestingly, we find that the enzymatic
activity is required for both activation and repression of
genes by KDM5A (Figure 8A). Importantly, with the ex-
ception of the proto-oncogenes Mdm2 and Ccnd1, there is
a requirement of the demethylase activity for the activation
of pro-proliferative cell cycle genes by KDM5A, suggesting
that the enzymatic activity of KDM5A is required for the
ability to induce the majority of KDM5A-activated cell cy-
cle genes in fibroblasts (Figure 8B and C).
DISCUSSION
In this study, we demonstrate that KD of the KDM5 family
impairs proliferation and differentiation inwhite and brown
preadipocytes. We show that KD of the KDM5 histone
demethylases in 3T3-L1 preadipocytes results in a global
increase in H3K4me3 levels at promoters but that this has
little impact on gene expression per se. In contrast, our data
indicate that KDM5 can act as an activator of a subset of
cell cycle genes, and thatKDofKDM5 abrogates the induc-
tion of these genes in response to the adipogenic cocktail
(Figure 8D).
Our approach to simultaneously KD all expressed
KDM5 family members, i.e. KDM5A, KDM5B and
1754 Nucleic Acids Research, 2017, Vol. 45, No. 4
B
Control
KD
0.002
0.004
0.006
0.008
0.010
0.012
0.000
D0 4h 12h D1 D2 D3 D4 D6
Cdc6
Re
la
tiv
e 
ex
pr
es
si
on
***
***
**
***
*
0.20
0.15
0.10
0.05
0.25
0.30
0.35
0.40
0.45
0.00
D0 4h 12h D1 D2 D3 D4 D6
*
**
*
***
*
Cdc20
Re
la
tiv
e 
ex
pr
es
si
on
Time point
A
0.0 
0.1 
0.2 
0.3 
0.4 
0.00 
0.10 
0.20 
F Binding at cell cycle gene promoters, day 2
Ne
g. c
on
tro
l
E2f
2
Ccn
e2
Cd
c6
*
Plk
1
**
Ccn
a2
*
E2f
1
**
Cd
c20
**
Ne
g. c
on
tro
l
Cd
c6 Plk
1
Ccn
a2
Ccn
e2E2f
2
**
E2f
1
*
Cd
c20
***
Re
co
ve
ry
 (%
)
D
Lo
g2
(t
ag
s/
kb
)
C
2
4
6
8
10
12
Induced cell cycle genes
Lo
g2
(t
ag
s/
kb
)
Day 0 Day 24 hours
64 cell cycle genes induced
from day 0 to 2 in control cells
#
Oxidative Stress
EGFR1 Signaling Pathway
Keap1−Nrf2
ErbB signaling pathway
FAS pathway and Stress induction of HSP regulation
PodNet: protein−protein interactions in the podocyte
G Protein Signaling Pathways
Glycogen Metabolism
Toll Like Receptor signaling
mRNA processing
Proteasome Degradation
G1 to S cell cycle control
DNA Replication
Cell cycle
300
-LogP
KD
M
5-
ac
tiv
at
ed
KD
M
5-
un
ch
an
ge
d
KD
M
5-
re
pr
es
se
d
WikiPathways
Al
l g
en
es
In
du
ce
d
Re
pr
es
se
d
Cell cycle 
gene groups 
#
#
4
5
6
7
8
9
KDM5A promoter sites 
C5MDKA5MDK
Control
KD
0.25 
0.15 
0.05 
E2f1
150
150
chr2:
KDM5A
Input
154,392,000 154,396,000
Ccna2
150
150
chr3:
KDM5A
Input
36,468,000 36,472,000
Bbs7
118,112,000
Cdc20
150
150
chr4:
KDM5A
Input
118,108,000
E
98,768,000 98,773,000
5 kb
Cdc6
150
150
chr11:
KDM5A
Input
129,305,000
Plk1
150
150
chr7:
KDM5A
Input
129,309,000
Figure 6. Cell cycle genes are dysregulated in KDM5 KD cells. (A) KDM5-repressed genes, KDM5-activated genes, and genes with KDM5A binding
in their promoter but unchanged by KD were subjected to functional enrichment analyses. The heat map shows the enrichment (reported as -LogP) for
the top 5 WikiPathways in each category. (B) mRNA levels of Cdc6 (top) and Cdc20 (bottom) during the course of adipocyte differentiation in control
(blue) and KDM5 KD (red) cells. Error bars represent SD (n = 3). P-value: *P < 0.05, **P <0.01, and ***P <0.005, control compared with KDM5 KD,
Student’s two-tailed t-test. (C) Box plots illustrating log2 normalized gene signal (as tags per kb) during differentiation from day 0 to day 2 of induced cell
cycle genes from the KEGG database annotation in control (blue) and KDM5 KD (red) cells. (D) Box plot showing log2 normalized KDM5A signal at
day 2 (as tags per kb) in the KDM5A-occupied promoters of all analyzed genes (gray), as well as cell cycle genes from the KEGG database annotation that
are either induced (green) or repressed (red) from day 0 to day 2 of differentiation. (E) ChIP-seq profiles of KDM5A at the Cdc6, Cdc20, E2f1, Plk1, and
Ccna2 loci at day 2. C and D: P-value: # P <0.05, Wilcoxon rank sum test as indicated. (F) ChIP-qPCR of KDM5A (left) and KDM5C (right) binding at
promoters of selected pro-proliferative genes in control (blue) and KDM5 KD (red) cells presented as percent recovery of input. P-value: *P <0.05, **P
<0.01, and ***P <0.005, positive targets versus negative control (neg. control) as well as control versus KDM5 KD, Student’s two-tailed t-test.
Nucleic Acids Research, 2017, Vol. 45, No. 4 1755
B
O
D
 (4
50
nm
)
0-12h 24-48h
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
**
BrdU proliferation 
assay, 3T3-L1 cells
Control
KD
C
Day
Re
la
tiv
e 
to
 c
on
tr
ol
 d
ay
 -1
BAT-LgT cell counting
Control
KD
0
1
2
3
5
6
7
-3 -1 1 3 5 7 9
4
*
**
**
***
***
Day
A
**
**
*
***
3T3-L1 cell counting
Re
la
tiv
e 
to
 c
on
tr
ol
 d
ay
 -2
0
1
2
3
4
-3 -1 1 3 5 7
Control
KD
Oil red O day 7,
BAT-LgT cells
D
Re
la
tiv
e 
O
RO
 s
ig
na
l p
er
 c
el
l
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
1.2 
1.4 
*
Control
KD
E mRNA day 6, BAT-LgT cells
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
1.2 
Fabp4 Plin1 Plin2 Lpl 
Re
la
tiv
e 
ex
pr
es
si
on
Ucp1
*** *
Figure 7. KDM5 KD impairs proliferation in both 3T3-L1 and BAT-LgT differentiating cells. (A) Cell counting at the indicated time points during
differentiation in control (blue) and KDM5 KD (red) 3T3-L1 cells. The data is presented as a mean of three independent biological replicates and error
bars represent SD (n = 3). (B) BrdU assay performed in 3T3-L1 cells between time of induction of differentiation and 12 h later (0–12 h) and day 1 to 2
after induction of differentiation (24–48 h). Error bars represent SD (n = 5), and the data is representative of two independent biological replicates. (C)
Pre-confluent (day -4) BAT-LgT preadipocytes were transduced with lentivirus expressing either control luciferase shRNA (Control) or shRNA targeting
KDM5A, KDM5B and KDM5C (KD). Cell counting at the indicated time points in the differentiation in control (blue) and KDM5 KD (red) BAT-LgT
cells. Error bars represent SD (n = 3). (D) Quantification of Oil red O staining at day 7 of differentiation in BAT-LgT control (blue) and KDM5 KD (red)
cells presented as Oil red O (ORO) signal per cell relative to control. (E) mRNA levels of uncoupling protein 1 (Ucp1) and adipocyte marker genes at day
6 in control (blue) and KDM5 KD (red) BAT-LgT cells. Error bars represent standard deviation (SD) (n = 3). *P < 0.05, **P < 0.01, and ***P < 0.005,
Student’s two-tailed t-test.
KDM5C, prevents masking of important functions of
KDM5 demethylases due to redundancy and functional
compensation between the subtypes. The fourth KDM5
family member, KDM5D, is not expressed in 3T3-L1 cells.
The gene encoding KDM5D is found on the Y chromo-
some, which is present in 3T3-L1 preadipocytes but based
on RNA-seq data appears to be completely silenced. We
show thatKDofKDM5 in 3T3-L1 preadipocytes leads to a
large global increase in H3K4me3 promoter levels, thereby
indicating that the KDM5 family is a major determinant
of the level of H3K4me3 at promoters in these cells. Pre-
vious studies have assessed the effects of KD of individual
KDM5 family members on H3K4me3 levels and arrived at
different conclusions. Thus, in accordance with our obser-
vations, a global increase in H3K4me3 levels was reported
in response to KDM5A KD in human gastric cancer cells
(13), whereas no global changes were observed in KDM5A
KO MEFs (7). Depletion of KDM5B resulted in a global
increase in H3K4me3 levels in ESCs (23) and breast cancer
cells (88) but not in neuronal stem cells (23). By contrast,
KDM5BKD inMCF7 cells (17) andKDM5CKD in ESCs
(38) only resulted in local site-specific effects on H3K4me3
levels. The differences in the results obtained are likely due
to the redundancy between KDM5 family members and
the different cellular contexts of the studies. High levels of
H3K4me3 are generally associated with active promoters
(1,29,33). Our finding that the increase in gene expression
of a subset of genes correlates strongly with the increase in
promoter H3K4me3 levels is consistent with that. However,
the fact that the robust increase in the H3K4me3 mark at
promoters upon KDM5KD is not correlated with gene ex-
pression indicates that increased deposition of H3K4me3 is
generally insufficient for activation of gene expression.
Members of the KDM5 family have been reported as
both activators and repressors of gene transcription depen-
dent on the cellular context (3,12–14,17,21–23,27,28,34–
38,76,88). Interestingly, we show that high KDM5A bind-
ing appears to predispose promoters for early activation
during 3T3-L1 differentiation and that KD of KDM5
leads to diminished activation of many of these genes,
thereby suggesting a direct role of KDM5 in the transcrip-
tional activation of this subset of target genes. Notably,
KDM5-activated promoters typically have high KDM5A
and KDM5C occupancy, and high levels of H3K4me3
and promoter activity, whereas KDM5-repressed promot-
ers generally have low KDM5A and KDM5C occupancy
and low levels of H3K4me3 and promoter activity. Thus,
KDM5 appears to function as a repressor at some promot-
ers, which are generally low occupancy sites, whereas it acts
as an activator of a subset of high KDM5 occupancy pro-
moters. In line with this, lysine-specific histone demethylase
1A (KDM1A/LSD1) was recently shown to exert a dual
role at androgen-regulated enhancers, where LSD1 medi-
ates the removal of the H3K4me2 mark, but still acts as a
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coactivator probably through demethylation of other his-
tone or non-histone substrates (89).
The molecular basis for this apparent dual role of the
KDM5s in the regulation of promoter activity is unclear;
however, it is possible that this is controlled by a promoter
context-dependent balance between the coactivator func-
tion and the H3K4me3 demethylase activity. In this regard
it is interesting that KDM5-activated promoters are gener-
ally devoid of a TATA box, but have a high prevalence of
CpG islands. Furthermore, the E2F binding motif is highly
enriched in the group of KDM5-actived promoters. Impor-
tantly, our data suggest that the ability of KDM5A to re-
press and activate gene transcription is dependent on its
demethylase domain. The mechanisms leading to this de-
pendency remain unknown, but may involve demethylation
of associated transcription factors and cofactors.
Interestingly, we show that cell cycle genes are among the
most highly enriched gene pathway in the group of KDM5-
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activated target genes and that KD of the KDM5s leads
to impairment of early stage 3T3-L1 adipogenesis includ-
ing mitotic clonal expansion in response to the differentia-
tion cocktail. Since mitotic clonal expansion is required for
adipocyte differentiation of 3T3-L1 adipocytes, it is likely
that KDM5 KD interferes with adipocyte differentiation
at least in part by interfering with post confluent prolif-
erative potential. Consistent with that, if the KDM5s are
knocked down at day 2, i.e. after activation of the second
wave of adipogenic transcription factors (including PPAR
and C/EBP) and after the post-confluent mitoses, adipo-
genesis is not significantly inhibited. KDM5 KD in BAT-
LgT cells, which is a SV40 large-T antigen-immortalized
brownpreadipocytemodel, reduced both the ability of these
cells to proliferate and to accumulate lipids in response dif-
ferentiation inducers. Some previous studies have reported a
similar pro-proliferative role of the KDM5s (12–14,17,18),
whereas the KDM5s in other cellular systems have been
reported to be anti-proliferative (21,22,34,90,91). The very
different cellular contexts of the studies, including malig-
nant cell models, are likely responsible for the different
functions assigned to the KDM5s. Our data show that
the KDM5s have pro-proliferative effects in fibroblasts and
preadipocytes and indicate that this is mediated by directly
promoting the activation of the pro-proliferative cell cycle
gene promoters. This may also have important mechanistic
implications in other biological systems, since the KDM5
family is known to promote tumor growth in different can-
cer settings.
In conclusion, we show that members of the KDM5 fam-
ily are required for mitotic clonal expansion and differenti-
ation of 3T3-L1 preadipocytes and for post-confluent mi-
toses and full differentiation of the brown preadipocyte cell
line BAT-LgT into mature adipocytes. KDM5 plays a key
role in modulating the level of H3K4me3 at promoters of
3T3-L1 preadipocytes, but changes inH3K4me3 have a lim-
ited effect per se on gene expression. Instead, during early
stage adipogenesis, the KDM5s appear to act as direct dual
coregulators that, depending on the context, activate some
promoters while repressing others. Specifically, the KDM5s
appear to be exerting their main action on adipogenesis as
direct coactivators of a subset of promoters, including pro-
moters driving pro-proliferative cell cycle genes. Future in-
vestigation should delineate the molecular basis for the ap-
parent dual role of the KDM5s as corepressors and coacti-
vators.
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